347 related articles for article (PubMed ID: 18565176)
1. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
Pollreisz A; Assinger A; Hacker S; Hoetzenecker K; Schmid W; Lang G; Wolfsberger M; Steinlechner B; Bielek E; Lalla E; Klepetko W; Volf I; Ankersmit HJ
Br J Dermatol; 2008 Sep; 159(3):578-84. PubMed ID: 18565176
[TBL] [Abstract][Full Text] [Related]
2. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins.
Cognasse F; Hamzeh-Cognasse H; Lafarge S; Chavarin P; Cogné M; Richard Y; Garraud O
Exp Hematol; 2007 Sep; 35(9):1376-87. PubMed ID: 17656005
[TBL] [Abstract][Full Text] [Related]
3. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
[TBL] [Abstract][Full Text] [Related]
4. CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia.
Ankersmit HJ; Roth GA; Moser B; Zuckermann A; Brunner M; Rosin C; Buchta C; Bielek E; Schmid W; Jensen-Jarolim E; Wolner E; Boltz-Nitulescu G; Volf I
Am J Transplant; 2003 Jun; 3(6):754-9. PubMed ID: 12780568
[TBL] [Abstract][Full Text] [Related]
5. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
Skripchenko A; Kurtz J; Moroff G; Wagner SJ
Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
[TBL] [Abstract][Full Text] [Related]
6. Characterization of soluble CD40 ligand released from human activated platelets.
Jin Y; Nonoyama S; Morio T; Imai K; Ochs HD; Mizutani S
J Med Dent Sci; 2001 Mar; 48(1):23-7. PubMed ID: 12160239
[TBL] [Abstract][Full Text] [Related]
7. Significance of platelet and monocyte activation for therapeutic immunoglobulin-induced thromboembolism.
Salge-Bartels U; Heiden M; Groß N; Seitz R
Thromb Res; 2014 Feb; 133(2):244-53. PubMed ID: 24342536
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
9. Human intravenous immunoglobulin (hIVIG) inhibits anti-CD32 antibody binding to canine DH82 cells and canine monocytes in vitro.
Sibley TA; Miller MM; Fogle JE
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):229-34. PubMed ID: 23276750
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin preparations promote apoptosis in lipopolysaccharide-stimulated neutrophils via an oxygen-dependent pathway in vitro.
Takeshita S; Tsujimoto H; Nakatani K
APMIS; 2005 Apr; 113(4):269-77. PubMed ID: 15865608
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of platelet aggregation induced by HLA-related antibodies.
Brandt JT; Julius CJ; Osborne JM; Anderson CL
Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
[TBL] [Abstract][Full Text] [Related]
12. Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner.
Lebrazi J; Helft G; Abdelouahed M; Elalamy I; Mirshahi M; Samama MM; Lecompte T
Thromb Haemost; 1995 Sep; 74(3):938-42. PubMed ID: 8571325
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
[TBL] [Abstract][Full Text] [Related]
14. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L
Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
[TBL] [Abstract][Full Text] [Related]
15. A novel anti-platelet monoclonal antibody induces mouse platelet aggregation through an Fc receptor-independent mechanism.
Kato Y; Hori S; Fujita N; Tsuruo T
Biochem Biophys Res Commun; 1998 Jan; 242(2):250-5. PubMed ID: 9446779
[TBL] [Abstract][Full Text] [Related]
16. Off-target platelet activation in macaques unique to a therapeutic monoclonal antibody.
Santostefano MJ; Kirchner J; Vissinga C; Fort M; Lear S; Pan WJ; Prince PJ; Hensley KM; Tran D; Rock D; Vargas HM; Narayanan P; Jawando R; Rees W; Reindel JF; Reynhardt K; Everds N
Toxicol Pathol; 2012 Aug; 40(6):899-917. PubMed ID: 22552394
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
MacMillan HF; Lee T; Issekutz AC
Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
[TBL] [Abstract][Full Text] [Related]
18. IgG-complex stimulated platelets: a source of sCD40L and RANTES in initiation of inflammatory cascade.
Antczak AJ; Singh N; Gay SR; Worth RG
Cell Immunol; 2010; 263(1):129-33. PubMed ID: 20378102
[TBL] [Abstract][Full Text] [Related]
19. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation.
Nomura S; Nakamura T; Cone J; Tandon NN; Kambayashi J
Cytometry; 2000 Jul; 40(3):173-81. PubMed ID: 10878559
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
Miescher SM; Huber TM; Kühne M; Lieby P; Snydman DR; Vensak JL; Berger M
Vox Sang; 2015 Jul; 109(1):71-8. PubMed ID: 25766313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
